Systemic hypertension and nondiabetic chronic kidney disease: the best evidence-based therapeutic approach today

T.H. Jafar

Section of Nephrology, Department of Medicine, Clinical Epidemiology Unit, Department of Community Health Sciences, Aga Khan University – Karachi (Pakistan)
Division of Nephrology, Tufts-New England Medical Center, Department of Medicine, Tufts University School of Medicine – Boston, MA (USA)

---

• Nephrology

Abstract. – Despite the high prevalence and significant morbidity and mortality associated with high chronic kidney disease (CKD) in patients with hypertension, it remains vastly under-diagnosed and under-treated. Consequently, many patients develop kidney failure requiring dialysis or kidney transplant. Moreover, patients with CKD represent the group at highest risk from cardiovascular complications, even greater than patients with diabetes mellitus. Therefore, management of hypertension in such patients needs to be more aggressive compared to those with normal kidney function. This review provides guidelines for treatment of hypertension in patients with non-diabetic CKD based on updated evidence from clinical trials data. Following these recommendations is likely to minimize the risk of development of kidney failure and cardiovascular disease.

Free PDF Download